methylprednisolone has been researched along with nintedanib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Burbujo, J; Calderón-Komaromy, A; Córdoba, S; de Pablo, NP; Freites-Martínez, A; Martinez-Sánchez, D | 1 |
Ismail, I; Nigam, S; Parnham, A; Srinivasa, V | 1 |
Chen, X; Hu, J; Li, Y; Luo, C; Zuo, X | 1 |
3 other study(ies) available for methylprednisolone and nintedanib
Article | Year |
---|---|
[Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy].
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Susceptibility; Female; Fusidic Acid; Hand; Humans; Indoles; Methylprednisolone; Middle Aged; Onycholysis; Paclitaxel; Paronychia; Staphylococcal Skin Infections | 2014 |
Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report.
Topics: Anti-Glomerular Basement Membrane Disease; Antineoplastic Agents; Cyclophosphamide; Female; Glomerulonephritis; Hematuria; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Methylprednisolone; Middle Aged; Plasma Exchange; Prednisone; Remission Induction; Treatment Outcome | 2017 |
Pulmonary fibrosis and cytokine release syndrome after hyperactivation with sintilimab.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Colonic Neoplasms; Cytokine Release Syndrome; Glucocorticoids; Humans; Immunotherapy; Indoles; Male; Methylprednisolone; Middle Aged; Pulmonary Fibrosis | 2020 |